Search Results

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG) by Kasper, Bernd (Author) , Rauch, Geraldine (Author) , Limprecht, Ronald (Author) , Sommer, Michaela (Author) , Dimitrakopoulou-Strauss, Antonia (Author) , Pilz, Lothar R. (Author) , Hohenberger, Peter (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal: implications for targeted therapies by Schneider, Meike (Author) , Korzeniewski, Nina (Author) , Merkle, Konstanze (Author) , Schuler, Julia (Author) , Grüllich, Carsten (Author) , Hadaschik, Boris (Author) , Hohenfellner, Markus (Author) , Duensing, Stefan (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Clinical trials in chronic myeloid leukemia by Saußele, Susanne (Author) , Pfirrmann, Markus (Author) ,


    Get full text
    Article (Journal) Online Resource
  4. 4

    Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells by Radujković, Aleksandar (Author) , Fruehauf, Stefan (Author) , Zeller, W. Jens (Author) , Ho, Anthony Dick (Author) , Topaly, Julian (Author) ,


    Get full text
    Article (Journal) Online Resource